StockClub

VYGR

VYGRVoyager Therapeutics, Inc.$ --
Voyager Therapeutics, Inc.

Voyager Therapeutics, Inc.

VYGR

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
3M USD
YoY -59.9%
Operating Income
-30M USD
YoY +12.7%
Net Income
-28M USD
YoY +9.9%
EPS
-0.47$
YoY +11.3%

Revenue

$2.6M
FY2024 Q2$49.1M
$49.1M
Q2
FY2024 Q3$73.7M
$73.7M
Q3
FY2024 Q4$80M
$80M
Q4
FY2025 Q1$6.5M
$6.5M
Q1
FY2025 Q2$11.7M
$11.7M
Q2
FY2025 Q3$25M
$25M
Q3
FY2025 Q4$40.4M
$40.4M
Q4
FY2026 Q1$2.6M
$2.6M
Q1
Actual
$-3.9M (-59.9%)

Net Income

$-27.9M
FY2024 Q2$-21.5M
$-21.5M
Q2
FY2024 Q3$-30.5M
$-30.5M
Q3
FY2024 Q4$-65M
$-65M
Q4
FY2025 Q1$-31M
$-31M
Q1
FY2025 Q2$-64.4M
$-64.4M
Q2
FY2025 Q3$-92.3M
$-92.3M
Q3
FY2025 Q4$-119.7M
$-119.7M
Q4
FY2026 Q1$-27.9M
$-27.9M
Q1
Actual
+$3.1M (+9.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$171.1M
Est:$180.4M
FY2020MISS
$171.1M
FY2021BEAT
Actual:$37.4M
Est:$13.6M
FY2021BEAT
$37.4M
FY2022MISS
Actual:$40.9M
Est:$46.2M
FY2022MISS
$40.9M
FY2023BEAT
Actual:$250M
Est:$143.8M
FY2023BEAT
$250M
FY2024MISS
Actual:$80M
Est:$90.3M
FY2024MISS
$80M
FY2025BEAT
Actual:$40.4M
Est:$35.5M
FY2025BEAT
$40.4M

Analyst Estimates